Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Uncovering senescent fibroblast heterogeneity connects DNA damage response to idiopathic pulmonary fibrosis.

npj aging·2026

Same author

Early-stage type 1 diabetes: is there a role for lifestyle modifications?

The lancet. Diabetes & endocrinology·2026

Same author

Decoherence via Demyelination Hypothesis (DDH): A Mechanism of Cognitive Decline During Aging.

bioRxiv : the preprint server for biology·2026

Same author

Deubiquitinases at organelle quality control bottlenecks in neurodegeneration.

Trends in molecular medicine·2026

Same author

Exceptional Longevity Modifying Allele APOE2 Promotes DNA Signaling Pathways Resisting Cellular Senescence in Human Neurons.

Aging cell·2026

Same author

Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

IGF-1: elixir for motor neuron diseases.

Theodora Papanikolaou¹, Lisa M Ellerby

¹The Buck Institute for Age Research, Novato, CA 94945, USA.

|August 15, 2009

Summary

This summary is machine-generated.

Modulating testosterone levels offers a therapeutic strategy for spinal and bulbar muscular atrophy (SBMA). Research shows insulin growth factor is a promising therapeutic candidate for this motor neuron disease.

More Related Videos

Axonal Transport of Organelles in Motor Neuron Cultures using Microfluidic Chambers System

Axonal Transport of Organelles in Motor Neuron Cultures using Microfluidic Chambers System

Published on: May 5, 2020

Isolation and Culture of Oculomotor, Trochlear, and Spinal Motor Neurons from Prenatal Islmn:GFP Transgenic Mice

Isolation and Culture of Oculomotor, Trochlear, and Spinal Motor Neurons from Prenatal Isl^mn:GFP Transgenic Mice

Published on: November 12, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Axonal Transport of Organelles in Motor Neuron Cultures using Microfluidic Chambers System

Axonal Transport of Organelles in Motor Neuron Cultures using Microfluidic Chambers System

Published on: May 5, 2020

Isolation and Culture of Oculomotor, Trochlear, and Spinal Motor Neurons from Prenatal Islmn:GFP Transgenic Mice

Isolation and Culture of Oculomotor, Trochlear, and Spinal Motor Neurons from Prenatal Isl^mn:GFP Transgenic Mice

Published on: November 12, 2019

Area of Science:

Neuroscience
Endocrinology
Genetics

Background:

Spinal and bulbar muscular atrophy (SBMA) is a progressive neurodegenerative disease caused by a polyglutamine expansion in the androgen receptor.
Current therapeutic strategies for SBMA primarily focus on modulating androgen receptor signaling, often involving testosterone suppression.

Discussion:

The study by Palazzolo et al. investigates alternative therapeutic targets beyond direct testosterone modulation.
Evidence suggests that insulin-like growth factor (IGF) expression may play a crucial role in mitigating SBMA pathogenesis.

Key Insights:

Increased expression of insulin-like growth factor (IGF) demonstrates potential as a therapeutic intervention for SBMA.
This finding opens new avenues for treating SBMA by targeting growth factor pathways, complementing existing testosterone-modulating approaches.

Outlook:

Further research into IGF signaling pathways could lead to novel drug development for SBMA.
Exploring combination therapies involving IGF and testosterone modulation may offer synergistic benefits for patients.